Trial · NCT02364713
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Overall Survival | 5 years | All eligible and treated patients | Months | MEDIAN |
| SECONDARY | Progression-free Survival | 11 months | All eligible and treated patients | Months | MEDIAN |
| SECONDARY | Overall Survival | 12 months | All eligible and treated patients | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Progression-free Survival | 6 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Objective Response Rate | 11 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Incidence of Adverse Events Per Common Terminology Criteria for Adverse Events Version 4.0 | 12 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Quality of Life as Measured by the Functional Assessment of Cancer Therapy-Ovarian Questionnaire | 5 years | change in score | MEAN | |
| OTHER_PRE_SPECIFIED | Time Course of Viral Gene Expression and Virus Elimination and Biodistribution of Virally Infected Cells Using Single-photon Emission Computerized Tomography/Computed Tomography Imaging | Up to course 2 | |||
| OTHER_PRE_SPECIFIED | Viremia, Viral Replication, and Viral Shedding/Persistence Following Intraperitoneal Administration Within the Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Treatment Arm | Up to 5 years | |||
| OTHER_PRE_SPECIFIED | Humoral and Cellular Immune Responses to Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter | Up to 5 years | |||
| OTHER_PRE_SPECIFIED | Changes in Anti-ovarian Cancer Immune Responses in Both Treatment Arms | Baseline to up to 5 years | |||
| OTHER_PRE_SPECIFIED | Gene Expression Profile Predictive of Therapeutic Response to Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter | Up to 5 years |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02364713/outcomes